| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |